OLANZAPINE ODT TEVA ® 5 MG

País: Israel

Idioma: anglès

Font: Ministry of Health

ingredients actius:

OLANZAPINE 5 MG

Disponible des:

SALOMON,LEVIN & ELSTEIN LTD

Codi ATC:

N05AH03

formulario farmacéutico:

TABLETS ORODISPERSIBLE

Vía de administración:

PER OS

Fabricat per:

TEVA OPERATIONS POLAND SP.ZO.O

Grupo terapéutico:

OLANZAPINE

indicaciones terapéuticas:

Acute and maintenance treatment of schizophrenia. Olanzapine ODT Teva is indicated for the management of the manifestations of psychotic disorders. Olanzapine ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanzapine ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanzapine ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Data d'autorització:

2011-05-01